Home » Topics » BioWorld

BioWorld
RSS

GI Expects R&D To Keep It in the Red

Jan. 14, 1992

INTERNEURON GETS RIGHTS TO COMPOUNDS

Jan. 14, 1992

SANDOZ TO FUND AFFYMAX RESEARCH

Jan. 14, 1992

ENZO STOCK JUMPS AFTER MEETING

Jan. 14, 1992

TESTING SYSTEM FOR FASTER DRUG EVALUATION

Jan. 14, 1992

NYGENE AIMS TO SPEED MAb PRODUCTION

Jan. 13, 1992

OFFERINGS WINDOW HAS ITS LIMITS

Jan. 13, 1992

INTERNEURON TO REDEEM CLASS A WARRANTS

Jan. 13, 1992

MEDICIS TO REDEEM CLASS A WARRANTS

Jan. 13, 1992

APPOINTMENTS AND ADVANCEMENTS

Jan. 13, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.